Medicamen Biotech consolidated net profit rises 46.59% in the March 2021 quarter

Sales decline 9.69% to Rs 21.24 crore

Net profit of Medicamen Biotech rose 46.59% to Rs 3.65 crore in the quarter ended March 2021 as against Rs 2.49 crore during the previous quarter ended March 2020. Sales declined 9.69% to Rs 21.24 crore in the quarter ended March 2021 as against Rs 23.52 crore during the previous quarter ended March 2020.

For the full year,net profit declined 8.73% to Rs 12.13 crore in the year ended March 2021 as against Rs 13.29 crore during the previous year ended March 2020. Sales declined 10.18% to Rs 112.72 crore in the year ended March 2021 as against Rs 125.50 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales21.2423.52 -10 112.72125.50 -10 OPM %20.4312.54 -17.0615.23 - PBDT4.524.05 12 18.9120.48 -8 PBT4.103.38 21 16.3917.98 -9 NP3.652.49 47 12.1313.29 -9

Powered by Capital Market - Live News